U.S. Physical Therapy (NYSE:USPH) Price Target Raised to $120.00 at JPMorgan Chase & Co.

U.S. Physical Therapy (NYSE:USPH) had its price objective increased by JPMorgan Chase & Co. from $117.00 to $120.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 19.43% from the company’s current price.

A number of other brokerages also recently commented on USPH. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Bank of America reaffirmed a “neutral” rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st.

U.S. Physical Therapy Stock Up 1.1 %

USPH stock traded up $1.11 during trading on Tuesday, reaching $100.48. The stock had a trading volume of 16,440 shares, compared to its average volume of 93,081. U.S. Physical Therapy has a one year low of $76.18 and a one year high of $113.63. The company’s 50 day moving average is $86.93 and its two-hundred day moving average is $90.29. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of 106.89, a P/E/G ratio of 4.47 and a beta of 1.46.

Insiders Place Their Bets

In other news, Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the transaction, the director now directly owns 16,726 shares in the company, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the sale, the chief operating officer now owns 7,106 shares in the company, valued at approximately $684,236.74. The trade was a 19.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,896 shares of company stock valued at $656,940 over the last ninety days. 1.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Canada Pension Plan Investment Board purchased a new position in U.S. Physical Therapy in the 2nd quarter worth approximately $28,000. Innealta Capital LLC bought a new position in U.S. Physical Therapy in the second quarter valued at $30,000. Quest Partners LLC raised its position in U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after purchasing an additional 337 shares in the last quarter. Quarry LP raised its position in U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after purchasing an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC bought a new stake in U.S. Physical Therapy during the second quarter worth about $51,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.